Chen Chih-Ping
Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.
Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
J Med Ultrasound. 2022 Nov 9;30(4):257-260. doi: 10.4103/jmu.jmu_78_22. eCollection 2022 Oct-Dec.
Prenatal diagnosis of euploid increased nuchal translucency (NT) remains a challenge to obstetricians and genetic counselors although increased euploid NT at prenatal diagnosis can be associated with a favorable outcome. Prenatal diagnosis of euploid increased NT should include a differential diagnosis of pathogenetic copy number variants and RASopathy disorders (RDs) including Noonan syndrome (NS). Therefore, chromosomal microarray analysis, whole-exome sequencing, RD testing, and protein-tyrosine phosphatase, nonreceptor type 11 () gene testing may be necessary under such a circumstance. In this report, a comprehensive review of NS with its prenatal diagnosis and genetic testing is presented.
尽管产前诊断时整倍体胎儿颈部半透明带(NT)增厚可能与良好结局相关,但对产科医生和遗传咨询师而言,整倍体胎儿NT增厚的产前诊断仍是一项挑战。整倍体胎儿NT增厚的产前诊断应包括对致病性拷贝数变异和RAS病(RDs)(包括努南综合征(NS))进行鉴别诊断。因此,在这种情况下,可能需要进行染色体微阵列分析、全外显子测序、RD检测以及蛋白酪氨酸磷酸酶非受体11型(PTPN11)基因检测。在本报告中,将对NS及其产前诊断和基因检测进行全面综述。